TREA

98350578 - AVRILIOS

Follow

Information

  • Trademark
  • 98350578
  • Serial Number
    98350578
  • Filing Date
    January 10, 2024
    a year ago
  • Transaction Date
    January 24, 2025
    2 months ago
  • Status Date
    January 24, 2025
    2 months ago
  • Location Date
    January 24, 2025
    2 months ago
  • Status Code
    654
  • Current Location
    TMO LAW OFFICE 127
    Employee Name
    LOZEAU, BRANDON
  • Attorney Docket Number
    VAND-0273
    Attorney Name
    Jayme M. Torelli
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AVRILIOS
Case File Statements
  • GS0051: Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bile acid diarrhea; Pharmaceutical preparations for the treatment of tyrosine kinase inhibitor (TKI)-induced diarrhea; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of COVID-19; Pharmaceutical preparations for the treatment of inflammatory lung injury (ILI); Pharmaceutical preparations for the treatment of acute respiratory distress syndrome (ARDS); Pharmaceutical preparations for the treatment of social anxiety disorder; Pharmaceutical preparations for the treatment of performance anxiety; Pharmaceutical preparations for the treatment of public speaking anxiety; Pharmaceutical preparations for the treatment of circadian rhythm disorders; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder (DSPD); Pharmaceutical preparations for the treatment of non-24 hour sleep-wake disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndome; Pharmaceutical preparations for the treatment of nighttime sleep disturbances in patients with Smith-Magenis Syndrome (SMS); Pharmaceutical preparations for the treatment of major depressive disorder (MDD); Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of multiple myeloma; Pharmaceutical preparations for the treatment of Charcot-Marie-Tooth disease; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology
Case File Event Statements
  • 1/10/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/29/2024 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/9/2024 - 11 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/25/2024 - 8 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/9/2024 - 11 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/9/2024 - 11 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/9/2024 - 11 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/24/2024 - 8 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/24/2024 - 8 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/25/2024 - 8 months ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 7/25/2024 - 8 months ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 7/25/2024 - 8 months ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 1/24/2025 - 2 months ago
    13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC